Literature DB >> 27358853

Cutaneous metastasis as an initial presentation of lung adenocarcinoma with KRAS mutation: a case report and literature review.

Huijuan Liao1, Shenhong Wu1, Stephen R Karbowitz1, Nora Morgenstern1, David R Rose1.   

Abstract

Cutaneous metastasis as an initial presentation occurs in 0.8% of patients with internal malignancies, and is poorly understood in its molecular pathogenesis. We reported a case in which a 61-year-old male patient initially presented with rapidly growing skin nodule on his left chest wall, then developed dyspnea and loss of weight. Echocardiogram showed a large pericardial effusion with right ventricular collapse. PET/CT revealed moderate pleural effusion and multiple lymphadenopathies with hypermetabolic concentration of radiotracer in the lymph nodes as well as in the chest wall skin mass. Biopsy of the skin mass and pericardial/pleural fluids revealed metastatic adenocarcinoma consistent with lung primary with KRAS mutation. Palliative chemotherapy was administered without resulting in any improvement. This is the first case report to show that KRAS-mutant lung adenocarcinoma can be associated with cutaneous metastasis.

Entities:  

Keywords:  Cutaneous metastasis; KRAS mutation; lung adenocarcinoma

Year:  2014        PMID: 27358853      PMCID: PMC4923502          DOI: 10.3978/j.issn.2306-9759.2014.03.04

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  18 in total

Review 1.  Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?

Authors:  Patrick J Roberts; Thomas E Stinchcombe; Channing J Der; Mark A Socinski
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

Review 2.  A systematic overview of chemotherapy effects in non-small cell lung cancer.

Authors:  S Sörenson; B Glimelius; P Nygren
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

3.  Factors associated with long-term survival of patients with advanced non-small cell lung cancer.

Authors:  Etienne Giroux Leprieur; Armelle Lavole; Anne-Marie Ruppert; Valérie Gounant; Marie Wislez; Jacques Cadranel; Bernard Milleron
Journal:  Respirology       Date:  2012-01       Impact factor: 6.424

4.  Cutaneous and subcutaneous metastases of lung cancer. Clinical characteristics.

Authors:  S Dreizen; H M Dhingra; D F Chiuten; T Umsawasdi; M Valdivieso
Journal:  Postgrad Med       Date:  1986-12       Impact factor: 3.840

5.  Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients.

Authors:  D P Lookingbill; N Spangler; F M Sexton
Journal:  J Am Acad Dermatol       Date:  1990-01       Impact factor: 11.527

6.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

Review 7.  Skin metastases from lung cancer.

Authors:  Todd W Mollet; Carlos A Garcia; Glenn Koester
Journal:  Dermatol Online J       Date:  2009-05-15

Review 8.  Skin metastasis: a pathologist's perspective.

Authors:  Mahmoud Rezk Abdelwahed Hussein
Journal:  J Cutan Pathol       Date:  2009-11-17       Impact factor: 1.587

9.  Cutaneous metastasis: a meta-analysis of data.

Authors:  Richard A Krathen; Ida F Orengo; Ted Rosen
Journal:  South Med J       Date:  2003-02       Impact factor: 0.954

Review 10.  Tumor type-specific and skin region-selective metastasis of human cancers: another example of the "seed and soil" hypothesis.

Authors:  K A Kovács; B Hegedus; I Kenessey; J Tímár
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

View more
  3 in total

1.  Non-small cell lung cancer with distal cutaneous metastases in a patient with a previously treated colorectal carcinoma.

Authors:  D Thurston; T Hossain; N Waraich; A Shukla
Journal:  Ann R Coll Surg Engl       Date:  2016-03       Impact factor: 1.891

2.  Cutaneous metastases as a presenting sign of metastatic NSCLC.

Authors:  William T McSweeney; Kimberley Tan
Journal:  J Surg Case Rep       Date:  2019-10-10

3.  Cutaneous Metastasis from Lung Adenocarcinoma.

Authors:  Lingzhi Zhong; Dandan Mao; Houmin Li; Xue Chen; Jiang Jin; Guangdong Wen
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.